Original Research
Published on 07 Jan 2026
Pharmacovigilance insights: safety profiles of antifungal agents for invasive aspergillosis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1718019
- 893 views
335 articles related to "Safety Profiles"
Articles
Original Research
Published on 24 Sep 2024
Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455979
- 3,280 views
- 6 citations
Original Research
Published on 08 Nov 2016
Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00402
- 8,027 views
- 48 citations
Original Research
Published on 17 Mar 2023
Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2023.1109633
- 2,632 views
- 3 citations
Original Research
Published on 18 Feb 2026
Comparative safety profiles of risankizumab versus guselkumab: a pharmacovigilance study based on the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1765114
- 480 views
Original Research
Published on 12 Dec 2025
Real-world disproportionality analysis of sleep disturbances associated with antiseizure medications in epilepsy: a pharmacovigilance study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1740747
- 2,192 views
Mini Review
Published on 11 Aug 2014
Identification of Protective Antigens for Vaccination against Systemic Salmonellosis
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2014.00381
- 8,277 views
- 23 citations
Review
Published on 14 Jan 2026
Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1681709
- 994 views
Review
Published on 09 May 2024
Stem cell therapies: a new era in the treatment of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1389697
- 20,775 views
- 13 citations
Correction
Published on 15 Feb 2017
Corrigendum: Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00059
- 2,673 views
- 8 citations
Original Research
Published on 08 Oct 2025
The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1654735
- 3,485 views
Original Research
Published on 12 Jan 2026
Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
in Digital Public Health
Frontiers in Public Health
doi 10.3389/fpubh.2025.1721315
- 755 views
Editorial
Published on 28 Apr 2025
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1607362
- 1,823 views
- 1 citation
Original Research
Published on 27 May 2024
Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1256649
- 9,327 views
- 10 citations
Original Research
Published on 10 Feb 2025
Safety profiles of sevoflurane in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548376
- 4,974 views
- 2 citations
Original Research
Published on 06 Dec 2024
Characterizing ADRs of Enfortumab vedotin and Erdafitinib in bladder cancer treatment: a descriptive analysis from WHO-VigiAccess
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503154
- 3,791 views
- 7 citations